Grace Therapeutics, Inc.
GRCENasdaqCIK 1444192HealthcareFiscal year ends Mar 31
Reports and events: 370 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1816:06 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-037114 |
| 2026-08-1308:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032644 |
| 2026-08-1307:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-032632 |
| 2026-08-0616:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-031671 |
| 2026-07-2816:29 ET | DEF 14A | Proxy statementPeriod 2026-09-17 | 0001140361-26-029889 |
| 2026-07-2807:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-029837 |
| 2026-06-1808:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-025669 |
| 2026-06-1808:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-025667 |
| 2026-06-1807:31 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001140361-26-025662 |
| 2026-06-0516:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-024269 |
| 2026-04-2707:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-016834 |
| 2026-04-2314:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-016324 |
| 2026-02-1208:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-004927 |
| 2026-02-1207:31 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001140361-26-004924 |
| 2026-01-1217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-000995 |
| 2025-11-1716:22 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-09-30 | 0001140361-25-042491 |
| 2025-11-1308:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041807 |
| 2025-11-1307:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-041804 |
| 2025-10-2308:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-039020 |
| 2025-09-1808:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035337 |
| 2025-09-1216:13 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-034845 |
| 2025-08-2708:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032847 |
| 2025-08-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030400 |
| 2025-08-1207:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-030398 |
| 2025-07-2807:00 ET | DEF 14A | Proxy statementPeriod 2025-09-12 | 0001140361-25-027456 |
| 2025-06-2508:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023557 |
| 2025-06-2308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-023261 |
| 2025-06-2307:43 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001140361-25-023259 |
| 2025-04-0908:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-012944 |
| 2025-03-0308:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-006659 |
| 2025-02-1920:25 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-12-31 | 0001140361-25-005051 |
| 2025-02-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-004157 |
| 2025-02-1307:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001140361-25-004153 |
| 2025-02-1008:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-003645 |
| 2024-11-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-046314 |
| 2024-11-1307:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-046312 |
| 2024-10-2808:22 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-24-044363 |
| 2024-10-2508:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-044212 |
| 2024-10-0716:13 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-24-042968 |
| 2024-09-3016:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-042352 |
| 2024-09-2508:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-041832 |
| 2024-08-1616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-098049 |
| 2024-08-0908:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-094359 |
| 2024-08-0907:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094348 |
| 2024-06-2716:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-078447 |
| 2024-06-2108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-075880 |
| 2024-06-2107:30 ET | 10-K | Annual reportPeriod 2024-03-31 | 0000950170-24-075875 |
| 2024-04-0108:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-038882 |
| 2024-02-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-013568 |
| 2024-02-1207:30 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0000950170-24-013566 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.